|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2021
12 months to Jan 31, 2021
|
FY2020
12 months to Jan 31, 2020
|
FY2019
12 months to Jan 31, 2019
|
|
|---|---|---|---|---|---|
| Cash flows used in operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Accretion expense | |||||
| Interest on notes payable | |||||
| Amortization expense | |||||
| Foreign exchange, non-cash | |||||
| Foregiveness of debt | |||||
| Impairment of exploration and evaluation assets | |||||
| Share-based compensation for consulting services | |||||
| Adjustments for share-based payments | |||||
| Write-off of equipment | |||||
| Changes in operating assets and liabilities | |||||
| Increase (decrease) Prepaids and other receivables | |||||
| Increase (decrease) accounts payable | |||||
| Accrued liabilities | |||||
| Due to related parties | |||||
| AdjustmentsForDecreaseIncreaseInAccruedLiabilities | |||||
| Increase (decrease) in due to related parties | |||||
| Net cash used in operating activities | |||||
| Cash flows used in investing activities | |||||
| Acquisition of exploration and evaluation assets | |||||
| Acquisition of equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows provided by financing activities | |||||
| Issuance of notes payable to related parties | |||||
| Cash received on subscription to shares, net | |||||
| Payment of shares issuance costs | |||||
| Net cash provided by financing activities | |||||
| Effects of foreign currency exchange on cash | |||||
| Increase (decrease) in cash | |||||
| Cash and Cash equivalents | |||||
| Non-cash transactions | |||||
| Exploration and evaluation assets included in accounts payable | |||||
| Shares issued for exploration and evaluation assets, value | |||||
Loading...